Insulin-Like Growth Factor I Has a Direct Effect on Glucose and Protein Metabolism, but No Effect on Lipid Metabolism in Type 1 Diabetes

Journal of Clinical Endocrinology and Metabolism

Volumn 89, Issue 1, 2004, Pages 425-432

  Simpson, Helen L ^a   Jackson, Nicola C ^a   Shojaee Moradie, Fariba ^a   Jones, Richard H ^a   Russell Jones, David L ^c   Sönksen, Peter H ^a   Dunger, David B ^b   Umpleby, A Margot ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c ROYAL SURREY COUNTY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GLYCEROL; GROWTH HORMONE; INSULIN; ISOTOPE; LIPID; OCTREOTIDE; RECOMBINANT GROWTH HORMONE; RECOMBINANT SOMATOMEDIN C;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GLUCONEOGENESIS; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; GROWTH HORMONE RELEASE; HUMAN; HYPERINSULINEMIA; INHIBITION KINETICS; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; LIPID METABOLISM; LIPOLYSIS; LIVER FUNCTION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN METABOLISM;

ADULT; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; FATTY ACIDS, NONESTERIFIED; GLUCAGON; GLUCOSE; GLUCOSE CLAMP TECHNIQUE; GLYCEROL; HOMEOSTASIS; HUMAN GROWTH HORMONE; HUMANS; INSULIN; INSULIN-LIKE GROWTH FACTOR I; KINETICS; LEUCINE; LIPIDS; LIPOLYSIS; LIVER; METABOLIC CLEARANCE RATE; OXIDATION-REDUCTION; PLACEBOS; PROTEINS; RECOMBINANT PROTEINS;

EID: 0442326249     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2003-031274     Document Type: Article

References (50)

1. Yki-Jarvinen H, Koivisto VA 1986 Natural course of insulin resistance in type I diabetes. N Engl J Med 315:224-230
2. Jensen MD, Caruso M, Heiling V, Miles JM 1989 Insulin regulation of lipolysis in nondiabetic and IDDM subjects. Diabetes 38:1595-1601
3. Tessari P, Nosadini R, Trevisan R, De Kreutzenberg SV, Inchiostro S, Duner E, Biolo G, Marescotti MC, Tiengo A, Crepaldi G 1986 Defective suppression by insulin of leucine-carbon appearance and oxidation in type 1, insulin-dependent diabetes mellitus. Evidence for insulin resistance involving glucose and amino acid metabolism. J Clin Invest 77:1797-1804
4. Boni-Schnetzler M, Schmid C, Meier PJ, Froesch ER 1991 Insulin regulates insulin-like growth factor I mRNA in rat hepatocytes. Am J Physiol 260:E846-E851
5. Amiel SA, Sherwin RS, Hintz RL, Gertner JM, Press CM, Tamborlane WV 1984 Effect of diabetes and its control on insulin-like growth factors in the young subject with type I diabetes. Diabetes 33:1175-1179
6. Wurzburger MI, Sonksen PH 1996 Natural course of growth hormone hypersecretion in insulin-dependent diabetes mellitus. Med Hypotheses 46:145-149
7. Berelowitz M, Szabo M, Frohman LA, Firestone S, Chu L, Hintz RL 1981 Somatomedin-C mediates growth hormone negative feedback by effects on both the hypothalamus and the pituitary. Science 212:1279-1281
8. Bak JF, Moller N, Schmitz O 1991 Effects of growth hormone on fuel utilization and muscle glycogen synthase activity in normal humans. Am J Physiol 260:E736-E742
9. Moller N, Butler PC, Antsiferov MA, Alberti KG 1989: Effects of growth hormone on insulin sensitivity and forearm metabolism in normal man. Diabetologia 32:105-110
10. Moller N, Schmitz O, Moller J, Butler PC 1992 Effects of a physiological growth hormone pulse on substrate metabolism in insulin-dependent (type 1) diabetic subjects. J Clin Endocrinol Metab 75:432-436
11. Russell-Jones DL, Weissberger AJ, Bowes SB, Kelly JM, Thomason M, Umpleby AM, Jones RH, Sonksen PH 1993 The effects of growth hormone on protein metabolism in adult growth hormone deficient patients. Clin Endocrinol (Oxf) 38:427-431
12. Guler HP, Zapf J, Froesch ER1987 Short-term metabolic effects of recombinant human insulin-like growth factor I in healthy adults. N Engl J Med 317:137-140
13. Boulware SD, Tamborlane WV, Rennert NJ, Gesundheit N, Sherwin RS 1994 Comparison of the metabolic effects of recombinant human insulin-like growth factor-I and insulin. Dose-response relationships in healthy young and middle-aged adults. J Clin Invest 93:1131-1139
14. Hussain MA, Schmitz O, Mengel A, Glatz Y, Christiansen JS, Zapf J, Froesch ER1994 Comparison of the effects of growth hormone and insulin-like growth factor I on substrate oxidation and on insulin sensitivity in growth hormone-deficient humans. J Clin Invest 94:1126-1133
15. Russell-Jones DL, Bates AT, Umpleby AM, Hennessy TR, Bowes SB, Hopkins KD, Jackson N, Kelly J, Shojaee-Moradie F, Jones RH 1995 A comparison of the effects of IGF-I and insulin on glucose metabolism, fat metabolism and the cardiovascular system in normal human volunteers. Eur J Clin Invest 25:403-411
16. Laager R, Ninnis R, Keller U 1993 Comparison of the effects of recombinant human insulin-like growth factor-I and insulin on glucose and leucine kinetics in humans. J Clin Invest 92:1903-1909
17. Russell-Jones DL, Umpleby AM, Hennessy TR, Bowes SB, Shojaee-Moradie F, Hopkins KD, Jackson NC, Kelly JM, Jones RH, Sonksen PH 1994 Use of a leucine clamp to demonstrate that IGF-I actively stimulates protein synthesis in normal humans. Am J Physiol 267:E591-E598
18. Yakar S, Liu JL, Fernandez AM, Wu Y, Schally AV, Frystyk J, Chernausek SD, Mejia W, Le Roith D 2001 Liver-specific igf-1 gene deletion leads to muscle insulin insensitivity. Diabetes 50:1110-1118
19. Sjogren K, Wallenius K, Liu JL, Bohlooly Y, Pacini G, Svensson L, Tornell J, Isaksson OG, Ahren B, Jansson JO, Ohlsson C 2001 Liver-derived IGF-I is of importance for normal carbohydrate and lipid metabolism. Diabetes 50:1539-1545
20. Cheetham TD, Clayton KL, Taylor AM, Holly J, Matthews DR, Dunger DB 1994 The effects of recombinant human insulin-like growth factor I on growth hormone secretion in adolescents with insulin dependent diabetes mellitus. Clin Endocrinol (Oxf) 40:515-522
21. Carroll PV, Umpleby M, Ward GS, Imuere S, Alexander E, Dunger D, Sonksen PH, Russell-Jones DL 1997 rhIGF-I administration reduces insulin requirements, decreases growth hormone secretion, and improves the lipid profile in adults with IDDM. Diabetes 46:1453-1458
22. Acerini CL, Patton CM, Savage MO, Kernell A, Westphal O, Dunger DB 1997 Randomised placebo-controlled trial of human recombinant insulin-like growth factor I plus intensive insulin therapy in adolescents with insulin-dependent diabetes mellitus. Lancet 350:1199-1204
23. Thrailkill KM, Quattrin T, Baker L, Kuntze JE, Compton PG, Martha PM, Jr. 1999 Cotherapy with recombinant human insulin-like growth factor I and insulin improves glycémie control in type 1 diabetes. RhIGF-I in IDDM Study Group. Diabetes Care 22:585-592
24. Clemmons DR, Moses AC, McKay MJ, Sommer A, Rosen DM, Ruckle J 2000 The combination of insulin-like growth factor I and insulin-like growth factor-binding protein-3 reduces insulin requirements in insulin-dependent type 1 diabetes: evidence for in vivo biological activity. J Clin Endocrinol Metab 85:1518-1524
25. Scrimgeour CBWCAA 1988 A convemient method of screening glucose for 13C:12C ratio for use in stable isotope tracer studies. Biomed Environ Mass Spectrom 17:265-266
26. Sonksen PH 1976 Double antibody technique for the simultaneous detection of insulin and growth hormone. In: Anoniades HN, ed. Hormones in human blood: detection and assay. Cambridge: Harvard University Press; 176-179
27. Shojaee-Moradie F, Jackson C, Jones RH, Mallet AI, Hovorka R, Umpleby AM 1996 Quantitative measurement of 3-O-methyl-D-glucose by gas chromatography-mass spectrometry as a measure of glucose transport in vivo. J Mass Spectrom 31:961-966
28. Elia M, Khan K, Calder G, Kurpad A 1993 Glycerol exchange across the human forearm assessed by a combination of tracer and arteriovenous exchange techniques. Clin Sci 84:99-104
29. 13C]leucine. Am J Physiol 238:E473-E479
30. 13C)KIC in plasma by capillary gas chromatography/mass spectrometry in protein turnover studies. Biomed Mass Spectrom 12:432-436
31. Steele R 1959 Influence of gluocse loading and injected insulin on hepatic glucose output. Ann NY Acad Sci 82:420-430
32. 14C glucose. Recent Prog Horm Res 19:445-482
33. Mari A 1992 Estimation of the rate of appearance in the non-steady state with a two-compartment model. Am J Physiol 263:E400-E415
34. Caro JF, Poulos J, Ittoop O, Pories WJ, Flickinger EG, Sinha MK 1988 Insulin- like growth factor I binding in hepatocytes from human liver, human hepatoma, and normal, regenerating, and fetal rat liver. J Clin Invest 81:976-981
35. Yokota I, Hayashi H, Matsuda J, Saijo T, Naito E, Ito M, Ebina Y, Kuroda Y 1998 Effect of growth hormone on the translocation of GLUT4 and its relation to insulin-like and anti-insulin action. Biochim Biophys Acta 1404:451-456
36. Brown PM, Tompkins CV, Juul S, Sonksen PH 1978 Mechanism of action of insulin in diabetic patients: a dose-related effect on glucose production and utilisation. Br Med J 1:1239-1242
37. Cheetham TD, Taylor A, Holly JM, Clayton K, Cwyfan-Hughes S, Dunger DB 1994 The effects of recombinant human insulin-like growth factor-I (IGF-I) administration on the levels of IGF-I, IGF-II and IGF-binding proteins in adolescents with insulin-dependent diabetes mellitus. J Endocrinol 142:367-374
38. Lanes R, Recker B, Fort P, Lifshitz F 1985 Impaired somatomedin generation test in children with insulin-dependent diabetes mellitus. Diabetes 34:156-160
39. Wurzburger MI, Prelevic GM, Sonksen PH, Wheeler M, Balint-Peric L 1995 Effect of recombinant human growth hormone treatment on insulin-like growth factor (IGF-I) levels in insulin-dependent diabetic patients. Acta Diabetol 32:131-134
40. Finegood DT, Bergman RN, Vranic M 1988 Modeling error and apparent isotope discrimination confound estimation of endogenous glucose production during euglycemic glucose clamps. Diabetes 37:1025-1034
41. Levy JC, Brown G, Matthews DR, Turner RC 1989 Hepatic glucose output in humans measured with labeled glucose to reduce negative errors. Am J Physiol 257:E531-E540
42. Bolinder J, Lindblad A, Engfeldt P, Arner P 1987 Studies of acute effects of insulin-like growth factors I and II in human fat cells. J Clin Endocrinol Metab 65:732-737
43. Inoue Y, Copeland EM, Souba WW 1994 Growth hormone enhances amino acid uptake by the human small intestine. Ann Surg 219:715-722
44. Lucidi P, Lauteri M, Laureti S, Celleno R, Santoni S, Volpi E, Angeletti G, Santeusanio F, De Feo P 1998 A dose-response study of growth hormone (GH) replacement on whole body protein and lipid kinetics in GH-deficient adults. J Clin Endocrinol Metab 83:353-357
45. Heiling VJ, Campbell PJ, Gottesman IS, Tsalikian E, Beaufrere B, Gerich JE, Haymond MW 1993 Differential effects of hyperglycemia and hyperinsulinemia on leucine rate of appearance in normal humans. J Clin Endocrinol Metab 76:203-206
46. Umpleby AM, Boroujerdi MA, Brown PM, Carson ER, Sonksen PH 1986 The effect of metabolic control on leucine metabolism in type 1 (insulin-dependent) diabetic patients. Diabetologia 29:131-141
47. Tessari P, Nissen SL, Miles JM, Haymond MW 1986 Inverse relationship of leucine flux and oxidation to free fatty acid availability in vivo. J Clin Invest 77:575-581
48. Ferrannini E, Barrett EJ, Bevilacqua S, Jacob R, Walesky M, Sherwin RS, DeFronzo RA 1986 Effect of free fatty acids on blood amino acid levels in human. Am J Physiol 250:E686-E694
49. Beaufrere B, Chassard D, Broussolle C, Riou JP, Beylot M 1992 Effects of D-β-hydroxybutyrate and long- and medium-chain triglycerides on leucine metabolism in humans. Am J Physiol 262:E268-E274
50. Copeland KC, Nair KS 1994 Acute growth hormone effects on amino acid and lipid metabolism. J Clin Endocrinol Metab 78:1040-1047